TABLE 1.
Correlation between ESRP1 expression and clinicopathologic characteristics of NSCLC
| Variable | ESRP1 expression | X2 | p value | ||
|---|---|---|---|---|---|
| Total | −/+ | ++ | |||
| Age year | |||||
| <60 | 30 | 15 (23%) | 15 (23%) | 0.332 | 0.565 |
| ≥60 | 35 | 15 (23%) | 20 (31%) | ||
| Sex | |||||
| Male | 42 | 17 (26%) | 25 (38%) | 1.540 | 0.215 |
| Female | 23 | 13 (20%) | 10 (16%) | ||
| Smoking History | |||||
| Yes | 34 | 10 (16%) | 24 (37%) | 8.041 | 0.005 |
| No | 31 | 20 (30%) | 11 (17%) | ||
| Pathologic category | |||||
| Squamous cell carcinoma | 35 | 13 (20%) | 22 (34%) | 2.478 | 0.115 |
| Adenocarcinoma | 30 | 17 (26%) | 13 (20%) | ||
| Differentiation | |||||
| Poorly differentiated | 35 | 11 (17%) | 24 (37%) | 6.616 | 0.010 |
| Moderately‐well differentiated | 30 | 19 (29%) | 11 (17%) | ||
| TNM Stage | |||||
| T1 + T2 | 45 | 17 (26%) | 28 (43%) | 4.129 | 0.042 |
| T3 + T4 | 20 | 13 (20%) | 7 (11%) | ||
| Metastasis | |||||
| M0 | 57 | 23 (35%) | 34 (52%) | 6.275 | 0.012 |
| M1 | 8 | 7 (11%) | 1 (2%) | ||
| Lymph metastasis | |||||
| N0 | 40 | 21 (32%) | 19 (29%) | 1.685 | 0.194 |
| N1 + N2 | 25 | 9 (14%) | 16 (25%) | ||
p values <0.05 was considered significant.